UROY vs VST: which is the better buy in 2026?
On Alexandria's Compass, Vistra Corp. has the edge with a 83/100 score versus 82/100 for UROY. Here is how they stack up, factor by factor.
Uranium Royalty Corp.
NASDAQ:UROY
The only pure-play uranium royalty vehicle, levered to a price cycle that's still in its early innings with zero capex drag.
Full UROY analysisVistra Corp.
NYSE:VST
Vistra's nuclear and gas fleet is the best asset in America's power shortage, and the stock just got cheap enough to buy.
Full VST analysisFactor by factor
Get head-to-heads like this, free
Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is UROY or VST the better buy in 2026?
By Compass Score, Vistra Corp. (NYSE:VST) edges it at 83/100 versus 82/100 for UROY. Both scores update weekly and reflect a contrarian, forward-looking read, not a recommendation.
How does Alexandria compare UROY and VST?
Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.
Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.